SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-019537
Filing Date
2022-10-13
Accepted
2022-10-13 08:32:01
Documents
13
Period of Report
2022-10-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20221013.htm   iXBRL 8-K 71225
2 EX-99.1 crnx-ex99_1.htm EX-99.1 35344
  Complete submission text file 0000950170-22-019537.txt   233247

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crnx-20221013_pre.xml EX-101.PRE 9842
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crnx-20221013.xsd EX-101.SCH 2472
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crnx-20221013_lab.xml EX-101.LAB 13350
7 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20221013_htm.xml XML 4726
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 221308154
SIC: 2834 Pharmaceutical Preparations